Kasner MT, Courtenay-Luck N, DiNardo C, Post SM, et al. Anexelekto (Axl)/Mer Inhibitor Tamnorzatinib in Patients with Relapsed/Refractory Acute Myeloid Leukaemia: Results from a Phase I (Monotherapy) and Phase II (Combination with Venetoclax) Clinical Study. Acta Haematol 2026;149:553-563.
PMID: 41385448